What happened
The ISAPS global survey released on 29 September reported that breast lift grew 48 percent in a year across the 51 markets it tracks, the largest increase of any surgical procedure in the world. The American figures published a month earlier showed the same operation rising 8 percent to 156,131, fourth most common in the United States, while breast augmentation held second place. In Türkiye, breast lift was the third most performed procedure in the world by count, 58,330 operations. Last week a London breast clinic put the reason in a headline that patients have been using for two years: saggy breasts after weight-loss medication.
The medical literature caught up at the same time. A narrative review in Aesthetic Surgery Journal Open Forum in March set out what weight-loss drugs do to the breast and how surgeons should counsel for it; a review from a university plastic surgery department in Istanbul, published this week, covered the same ground for face, breast and body. And a 100-patient study in Plastic and Reconstructive Surgery in July answered the question every one of these patients asks me: implant, or my own tissue?
The common misconception
The misconception is that a breast that has deflated after weight loss needs an implant to look like a breast again. The reasoning sounds right: the volume went, so put volume back. What it misses is that the breast after major weight loss has not only lost volume; it has lost support. The skin envelope is larger than the tissue inside it, the gland sits low and spreads to the side, and the upper pole is empty. An implant placed into that envelope does not fix the envelope. It adds weight to a structure that has already shown it cannot hold weight, and the literature now says what that leads to.
The clinical reality
Weight loss empties the breast from the top down. Breast volume is mostly fat, and fat is what the drugs remove. The reviews describe the sequence consistently: loss of upper-pole fullness first, then descent of the nipple as the gland follows the fat downward, then widening of the base as the skin, no longer filled, spreads laterally. Asymmetry is common, because the two breasts rarely lose the same amount. None of this is specific to the medication; bariatric surgery has produced the same breast for twenty years. What is new is the number of patients and, often, the speed, which gives the skin less time to adapt.
Where there is enough tissue, the patient’s own breast is the better implant. The July study compared 100 consecutive women after massive weight loss: 64 had a lift with autoaugmentation, in which the surgeon reshapes the remaining gland and the tissue at the side of the chest into the upper pole, and 36 had a lift with an implant. The autoaugmentation group scored significantly higher on satisfaction with their breasts and with the outcome; their complications were mostly managed without surgery, while most complications in the implant group needed a return to the operating room; and recurrent sagging was more frequent with implants. The authors’ conclusion is unusually direct for a surgical paper: if sufficient breast tissue is available, implants should be avoided in this population, and if an implant is needed the patient should be told about the higher complication and revision rates. A German series of 136 autoaugmentation lifts in weight-loss patients reported 5 percent complications and 95 percent satisfaction, with a 17.6 percent rate of small revisions, which is the honest cost of shaping tissue that has been stretched.
A lift removes almost no volume, which surprises patients. The fear I hear most often is that a lift will leave the breast smaller. With the technique I use, the breast loses roughly 30 to 50 grams, mostly from the tissue toward the armpit, which is tissue most patients are glad to lose. The rest is repositioned, not removed: the gland is gathered, lifted and fixed higher on the chest wall, and the upper pole is filled from below. What the patient sees afterward is a breast that is slightly smaller on the scale and visibly fuller in the bra, because the volume is now where volume reads. The surgery removes skin, not breast.
Implants still have a place, and it is narrower than the market suggests. A woman who was small-breasted before the weight loss, and is now small and empty, does not have enough tissue to shape into an upper pole; for her, an implant under a lift is the right operation, with the warning the study attaches to it. A woman who was a full C before and is now a deflated C has the tissue, and in my practice she gets her own breast back without a foreign body. Between the two are the patients who have to choose, and my advice there is to accept a smaller, natural result over a larger one that depends on a device the stretched envelope may not hold. Patients who are considering an implant should also read what I have written about choosing implant size and about removing implants later, because both conversations begin here.
The timing rule is the same as for the face. I do not lift a breast that is still deflating. Weight stable for at least three months, nutrition checked, and a frank conversation about whether the patient intends to continue the medication, because the breast will follow the weight in either direction afterward. The Istanbul review published this week lists the same preconditions: weight stabilization, nutritional balance, and an individual assessment of the healing risk along the tension lines a lift creates. I have written about the face version of this rule; the breast is less forgiving, because a lift scar under tension on skin that is still shrinking is a scar that widens.
Breastfeeding, sensation and the scar are the three honest trade-offs. Breastfeeding after a lift can be possible, but every patient is different, and in general a reduction in the ability to breastfeed should be expected; a woman planning a pregnancy soon is a woman I advise to wait. Nipple sensation is preserved in most patients and reduced in some. And a lift leaves a scar, around the areola and vertically below it, sometimes along the fold as well; the scar is the price of the shape, and no technique that promises a lift without one has survived scrutiny.
The practical takeaway for patients
Send photographs standing, front and both sides, arms at your sides, and tell me your weight before and after, when it stabilized, and whether you are still taking the medication. If you have a photograph from before the weight loss, it helps me judge how much tissue there was to begin with.
Tell me the size you want to end up, not the size you were. Many patients want to be smaller and higher rather than as large as before; a lift alone gives exactly that.
Ask a surgeon who proposes an implant why your own tissue is not enough. There is a right answer, and it is anatomical. “To fill the upper pole” is not it, because a well-done lift does that with your own gland.
If the breast is one of several areas you want treated after weight loss, read where I draw the line on combined surgery: a breast lift counts as a major lift and takes one of the three places in a session.
Honest limits
The comparative study is retrospective, from one Austrian department, with a median follow-up under three years; its conclusion fits what I see, but it is one center’s experience and its implant patients may have been the ones with the least tissue to begin with, which would bias the comparison. The ISAPS growth figure is a survey estimate, and the 48 percent is from 51 countries, not the whole world. The breast-specific literature on weight-loss drugs is still thin, as both reviews say. My volume figure is from my own technique and will not apply to every lift; a surgeon who reduces as he lifts removes much more. And the breastfeeding statement is a general expectation, not a prediction for any one woman.
If your breasts have changed after weight loss and you want to know whether a lift alone would be enough, send unedited photographs and your weight history to +90 544 772 0772. The surgical team reviews them the same day.
Dr. Mustafa Aydınol is a plastic, reconstructive and aesthetic surgeon in Istanbul and a member of ISAPS.
Sources
- International Society of Aesthetic Plastic Surgery. ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2025: breast lift up 48 percent across 51 markets; Türkiye country tables. Published 29 September 2026. Link
- American Society of Plastic Surgeons. 2025 Plastic Surgery Statistics Report: breast lift 156,131 procedures, up 8 percent. Link
- Radacher L, Zaussinger M, Ehebruster G, et al. Autoaugmentation versus implant-based augmentation mastopexy after massive weight loss: quality-of-life, surgical, and aesthetic results, 100 patients. Plast Reconstr Surg, 2026. DOI
- Wolter A, Scholz T, Pluto N, et al. Mastopexy in massive weight loss patients: extended Ribeiro technique and LICAP flap autoaugmentation, 136 operations, complications 5.1 percent, satisfaction 95 percent. Handchir Mikrochir Plast Chir, 2017. DOI
- Nahabedian MY, Deva AK, Ahmed D, Fanzio P, Hammer J. GLP-1 receptor agonist-associated weight loss and aesthetic breast surgery: a narrative review and experience-based recommendations. Aesthet Surg J Open Forum, 2026. DOI
- Ersan M, Özturhan O. Effects of GLP-1 receptor agonists on aesthetic surgery practice: a contemporary review. Turk J Surg, 2026. DOI
